All results were consistently reflected in the specimens of NSCLC-BM patients that the CD206+ microglia were significantly more than the iNOS+ microglia (Fig. 1h and Supplementary Fig. S1c). This evidence concerns the gene MRC1 and non-small cell lung carcinoma.